Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(31)
Published: June 19, 2024
Abstract
Small
cell
lung
cancer
(SCLC)
is
a
highly
aggressive
malignancy
characterized
by
rapid
growth
and
early
metastasis
susceptible
to
treatment
resistance
recurrence.
Understanding
the
intra‐tumoral
spatial
heterogeneity
in
SCLC
crucial
for
improving
patient
outcomes
clinically
relevant
subtyping.
In
this
study,
whole
transcriptome‐wide
analysis
of
25
patients
at
sub‐histological
resolution
using
GeoMx
Digital
Spatial
Profiling
technology
performed.
This
deciphered
multi‐regional
heterogeneity,
distinct
molecular
profiles,
biological
functions,
immune
features,
subtypes
within
spatially
localized
histological
regions.
Connections
between
different
transcript‐defined
phenotypes
their
impact
on
survival
therapeutic
response
are
also
established.
Finally,
gene
signature,
termed
ITHtyper,
based
prevalence
levels,
which
enables
risk
stratification
from
bulk
RNA‐seq
profiles
identified.
The
prognostic
value
ITHtyper
rigorously
validated
independent
multicenter
cohorts.
study
introduces
preliminary
tumor‐centric,
regionally
targeted
transcriptome
resource
that
sheds
light
previously
unexplored
SCLC.
These
findings
hold
promise
improve
tumor
reclassification
facilitate
development
personalized
treatments
patients.
Advanced Science,
Journal Year:
2022,
Volume and Issue:
10(5)
Published: Dec. 18, 2022
Distant
metastasis
remains
the
major
cause
of
morbidity
for
breast
cancer.
Individuals
with
liver
or
brain
have
an
extremely
poor
prognosis
and
low
response
rates
to
anti-PD-1/L1
immune
checkpoint
therapy
compared
those
at
other
sites.
Therefore,
it
is
urgent
investigate
underlying
mechanism
resistance
develop
more
effective
immunotherapy
strategies
these
patients.
Using
single-cell
RNA
sequencing,
a
high-resolution
map
entire
tumor
ecosystem
based
on
44
473
cells
from
cancer
metastases
depicted.
Identified
by
canonical
markers
confirmed
multiplex
immunofluorescent
staining,
metastatic
features
remarkable
reprogramming
immunosuppressive
such
as
FOXP3+
regulatory
T
cells,
LAMP3+
tolerogenic
dendritic
CCL18+
M2-like
macrophages,
RGS5+
cancer-associated
fibroblasts,
LGALS1+
microglial
cells.
In
addition,
PD-1
PD-L1/2
are
barely
expressed
in
CD8+
cancer/immune/stromal
respectively.
Interactions
molecules
LAG3-LGALS3
TIGIT-NECTIN2
between
found
play
dominant
roles
escape.
summary,
this
study
dissects
intratumoral
heterogeneity
microenvironment
first
time,
providing
insights
into
most
appropriate
Molecular Cancer,
Journal Year:
2023,
Volume and Issue:
22(1)
Published: June 8, 2023
Abstract
Over
the
past
decade,
immune
checkpoint
inhibitors
(ICIs)
have
emerged
as
a
revolutionary
cancer
treatment
modality,
offering
long-lasting
responses
and
survival
benefits
for
substantial
number
of
patients.
However,
response
rates
to
ICIs
vary
significantly
among
individuals
types,
with
notable
proportion
patients
exhibiting
resistance
or
showing
no
response.
Therefore,
dual
ICI
combination
therapy
has
been
proposed
potential
strategy
address
these
challenges.
One
targets
is
TIGIT,
an
inhibitory
receptor
associated
T-cell
exhaustion.
TIGIT
diverse
immunosuppressive
effects
on
immunity
cycle,
including
inhibition
natural
killer
cell
effector
function,
suppression
dendritic
maturation,
promotion
macrophage
polarization
M2
phenotype,
differentiation
T
cells
regulatory
cells.
Furthermore,
linked
PD-1
expression,
it
can
synergize
PD-1/PD-L1
blockade
enhance
tumor
rejection.
Preclinical
studies
demonstrated
co-inhibition
in
enhancing
anti-tumor
improving
outcomes
several
types.
Several
clinical
trials
are
underway
evaluate
safety
efficacy
various
results
awaited.
This
review
provides
overview
mechanisms
treatment,
summarizes
latest
investigating
this
therapy,
discusses
its
prospects.
Overall,
represents
promising
therapeutic
approach
that
improve
treated
ICIs.
Drug Resistance Updates,
Journal Year:
2024,
Volume and Issue:
73, P. 101063 - 101063
Published: Feb. 1, 2024
This
study
aims
to
explore
the
function
and
mechanism
of
G
Protein-coupled
receptor
class
C
group
5
member
A
(GPRC5A)
in
docetaxel-resistance
liver
metastasis
breast
cancer.
Frontiers in Nutrition,
Journal Year:
2023,
Volume and Issue:
10
Published: Feb. 16, 2023
Metabolic
reprogramming
is
one
of
fourteen
hallmarks
tumor
cells,
among
which
aerobic
glycolysis,
often
known
as
the
“Warburg
effect,”
essential
to
fast
proliferation
and
aggressive
metastasis
cells.
Lactate,
on
other
hand,
a
ubiquitous
molecule
in
microenvironment
(TME),
generated
primarily
by
cells
undergoing
glycolysis.
To
prevent
intracellular
acidification,
malignant
remove
lactate
along
with
H
+
,
yet
acidification
TME
inevitable.
Not
only
does
highly
concentrated
within
serve
substrate
supply
energy
but
it
also
works
signal
activate
multiple
pathways
that
enhance
invasion,
intratumoral
angiogenesis,
well
immune
escape.
In
this
review,
we
aim
discuss
latest
findings
metabolism
particularly
capacity
extracellular
influence
microenvironment.
addition,
examine
current
treatment
techniques
employing
existing
medications
target
interfere
generation
transport
cancer
therapy.
New
research
shows
targeting
metabolism,
lactate-regulated
action
are
viable
therapy
strategies.
Journal of Experimental & Clinical Cancer Research,
Journal Year:
2023,
Volume and Issue:
42(1)
Published: Feb. 17, 2023
Circular
RNAs
(circRNAs)
have
important
regulatory
functions
in
cancer,
but
the
role
of
circRNAs
tumor
microenvironment
(TME)
remains
unclear.
Moreover,
we
also
explore
effects
si-circRNAs
loaded
nanoparticles
as
therapeutic
agent
for
anti-tumor
vivo.We
conducted
bioinformatics
analysis,
qRT-PCR,
EdU
assays,
Transwell
co-culture
system
and
multiple
orthotopic
xenograft
models
to
investigate
expression
function
circRNAs.
Additionally,
PLGA-based
with
were
used
evaluate
potential
nanotherapeutic
strategy
response.We
identified
oncogene
SERPINE2
derived
circRNA,
named
cSERPINE2,
which
was
notably
elevated
breast
cancer
closely
related
poor
clinical
outcome.
Functionally,
exosomal
cSERPINE2
shuttled
associated
macrophages
(TAMs)
enhanced
secretion
Interleukin-6
(IL-6),
leading
increased
proliferation
invasion
cells.
Furthermore,
IL-6
turn
EIF4A3
CCL2
levels
within
cells
a
positive
feedback
mechanism,
further
enhancing
biogenesis
promoting
recruitment
TAMs.
More
importantly,
developed
nanoparticle
si-cSERPINE2,
effectively
attenuated
progression
vivo.Our
study
illustrates
novel
mechanism
that
mediates
loop
between
TAMs
promote
progression,
may
serve
promising
treatment
cancer.
Frontiers in Endocrinology,
Journal Year:
2023,
Volume and Issue:
14
Published: March 23, 2023
Increasing
evidence
suggests
a
correlation
between
glycosylation
and
the
onset
of
cancer.
However,
clinical
relevance
glycosylation-related
genes
(GRGs)
in
uveal
melanoma
(UM)
is
yet
to
be
fully
understood.
This
study
aimed
shed
light
on
impact
GRGs
UM
prognosis.To
identify
most
influential
UM,
we
employed
AUCell
WGCNA
algorithms.
The
signature
was
established
by
integrating
bulk
RNA-seq
scRNA-seq
data.
patients
were
separated
into
two
groups
based
their
risk
scores,
GCNS_low
GCNS_high
groups,
differences
clinicopathological
correlation,
functional
enrichment,
immune
response,
mutational
burden,
immunotherapy
examined.
role
critical
gene
AUP1
validated
through
vitro
vivo
experiments.The
comprised
AUP1,
HNMT,
PARP8,
ARC,
ALG5,
AKAP13,
ISG20.
GCNS
significant
prognostic
factor
for
high
correlated
with
poorer
outcomes.
Patients
displayed
heightened
immune-related
characteristics,
such
as
cell
infiltration
scores.
In
experiments
showed
that
knockdown
led
drastic
reduction
viability,
proliferation,
invasion
capability
cells.Our
provides
an
independent
predictor
patient
survival
represents
starting
point
further
investigation
UM.
It
offers
novel
perspective
diagnosis
treatment
MedComm,
Journal Year:
2024,
Volume and Issue:
5(3)
Published: Feb. 28, 2024
Disruption
of
disulfide
homeostasis
during
biological
processes
can
have
fatal
consequences.
Excess
disulfides
induce
cell
death
in
a
novel
manner,
termed
as
"disulfidptosis."
However,
the
specific
mechanism
disulfidptosis
has
not
yet
been
elucidated.
To
determine
cancer
types
sensitive
to
and
outline
corresponding
treatment
strategies,
we
firstly
investigated
crucial
functions
regulators
pan-cancer
at
multi-omics
levels.
We
found
that
different
tumor
expressed
dysregulated
levels
regulators,
most
which
had
an
impact
on
prognosis.
Moreover,
calculated
activity
score
tumors
validated
it
using
multiple
independent
datasets.
Additionally,
was
correlated
with
classic
pathways
various
cancers.
Disulfidptosis
also
associated
immune
characteristics
could
predict
immunotherapy
outcomes.
Notably,
regulator,
glycogen
synthase
1
(
Molecular Cancer,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: May 8, 2024
Abstract
Background
The
hypoxic
tumor
microenvironment
is
a
key
factor
that
promotes
metabolic
reprogramming
and
vascular
mimicry
(VM)
in
ovarian
cancer
(OC)
patients.
ESM1,
secreted
protein,
plays
an
important
role
promoting
proliferation
angiogenesis
OC.
However,
the
of
ESM1
VM
OC
patients
has
not
been
determined.
Methods
Liquid
chromatography
coupled
with
tandem
MS
was
used
to
analyze
CAOV3
OV90
cells.
Interactions
between
PKM2,
UBA2,
SUMO1
were
detected
by
GST
pull-down,
Co-IP,
molecular
docking.
effects
ESM1-PKM2
axis
on
cell
glucose
metabolism
analyzed
based
ECAR
experiment.
biological
signaling
cells
tubule
formation,
transwell
assay,
RT‒PCR,
Western
blot,
immunofluorescence,
vivo
xenograft
experiments.
Results
Our
findings
demonstrated
hypoxia
induces
upregulation
expression
through
transcription
HIF-1α.
serves
as
crucial
mediator
interaction
PKM2
facilitating
SUMOylation
subsequent
formation
dimers.
This
process
Warburg
effect
facilitates
nuclear
translocation
ultimately
leading
phosphorylation
STAT3.
These
events
contribute
promotion
glycolysis
vasculogenic
mimicry.
Furthermore,
our
study
revealed
Shikonin
effectively
inhibits
consequently
preventing
dimers
thereby
inhibiting
glycolysis,
fatty
acid
synthesis
Conclusion
increases
transcriptional
regulation
HIF-1α
induce
dimerization
via
SUMOylation,
which
VM.
Journal of Translational Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Jan. 3, 2024
Abstract
Breast
cancer
(BC)
is
a
multifaceted
disease
characterized
by
distinct
molecular
subtypes
and
varying
responses
to
treatment.
In
BC,
the
phosphatidylinositol
3-kinase
(PI3K)
pathway
has
emerged
as
crucial
contributor
development,
advancement,
resistance
This
review
article
explores
implications
of
PI3K
in
predictive,
preventive,
personalized
medicine
for
BC.
It
emphasizes
identification
predictive
biomarkers,
such
PIK3CA
mutations,
utility
profiling
guiding
treatment
decisions.
The
also
discusses
potential
targeting
preventive
strategies
customization
therapy
based
on
tumor
stage,
subtypes,
genetic
alterations.
Overcoming
inhibitors
exploring
combination
therapies
are
addressed
important
considerations.
While
this
field
holds
promise
improving
patient
outcomes,
further
research
clinical
trials
needed
validate
these
approaches
translate
them
into
practice.
Graphical